Viewing Study NCT00918333


Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2026-02-21 @ 3:55 PM
Study NCT ID: NCT00918333
Status: COMPLETED
Last Update Posted: 2020-03-10
First Post: 2009-06-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Nasal Type Extranodal NK/T-cell Lymphoma View
None Anaplastic Large Cell Lymphoma View
None Angioimmunoblastic T-cell Lymphoma View
None B-cell Adult Acute Lymphoblastic Leukemia View
None Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue View
None Hepatosplenic T-cell Lymphoma View
None Nodal Marginal Zone B-cell Lymphoma View
None Post-transplant Lymphoproliferative Disorder View
None Primary Central Nervous System Non-Hodgkin Lymphoma View
None Recurrent Adult Acute Lymphoblastic Leukemia View
None Recurrent Adult Burkitt Lymphoma View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Recurrent Adult Hodgkin Lymphoma View
None Recurrent Adult Lymphoblastic Lymphoma View
None Recurrent Adult T-cell Leukemia/Lymphoma View
None Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma View
None Recurrent Grade 1 Follicular Lymphoma View
None Recurrent Grade 2 Follicular Lymphoma View
None Recurrent Grade 3 Follicular Lymphoma View
None Recurrent Mantle Cell Lymphoma View
None Recurrent Marginal Zone Lymphoma View
None Recurrent Mycosis Fungoides/Sezary Syndrome View
None Recurrent Small Lymphocytic Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
None Refractory Multiple Myeloma View
None Splenic Marginal Zone Lymphoma View
None T-cell Adult Acute Lymphoblastic Leukemia View
None Waldenström Macroglobulinemia View
Keywords: